SUMMARY A single oral dose of 2 g of sultamicillin and 1 g of probenecid was effective in the treatment of men with uncomplicated gonococcal urethritis caused by both penicillin sensitive strains of Neisseria gonorrhoeae and penicillinase producing strains of N gonorrhoeae (PPNG). Of 94 infected men who attended for at least one follow up examination, 91 (970o) were cured. The remaining three (3Wo) patients were still infected at follow up. Two of these patients had been re-exposed to an infected partner and were considered to be possible reinfections, while the third was deemed a treatment failure. Six of the 94 patients were infected with PPNG strains and all were successfully treated. Plasmid analysis of the PPNG strains showed Asian and African types both with and without transfer plasmid.
Introduction
Sultamicillin (Pfizer Laboratories, CP-49, 952-15) is a novel compound in which ampicillin and the P-lactamase inhibitor sulbactam (Pfizer Laboratories, 899 ) are linked as a double ester as shown in the figure. During absorption the compound is hydrolysed, delivering both ampicillin and sulbactam to the blood in equivalent molar proportions. Pharmacokinetic studies have shown that sultamicillin provides up to three times higher serum concentrations of ampicillin than would be achieved by giving an equivalent dose of ampicillin alone. ' Sulbactam (penicillanic acid sulphone) possesses potent inhibitory activity against a wide variety of both pericytoplasmic and secreted P-lactamases from Gram The effective dose of penicillin has, however, been increased step by step at regular intervals during the past few years to a level at which patient tolerance is seriously questioned. Whereas parenteral penicillin has been advocated for several years for many good reasons, recent practice has been to give a single supervised dose of a penicillin with probenecid by mouth. In 1972 the most satisfactory single dose oral treatment for gonorrhoea in both sexes was ampicillin 2 g with 1 g probenecid. 8 This treatment was simple, easy to administer, acceptable to most patients, and produced cure rates of over 95%. At present the practice in the United Kingdom varies,9 and the recommended dose in the United States has risen to Since then further reports have confirmed that genetic interchange between gonococci is occur ring. [14] [15] [16] In this study seven PPNG strains were isolated, one of which showed the African P-lactamase type with the additional conjugative plasmid. The plasmid analysis is shown in table II together with the MICs to ampicillin, sulbactam, and the combination (sultamicillin). The synergistic effect of ampicillin plus sulbactam for the four different PPNG strains is clearly shown.
The discovery of PPNG strains may change the therapeutic approach to the treatment of gonorrhoea since there is no way of predicting whether an infecting strain produces P-lactamase or not. Alternative regimens have been sought, hastened by early reports of spectinomycin resistant PPNG.'7 Slack et al suggested treatment with cefotaxime,'8 while Tupasi et al had success with oral cefaclor.'9 For disseminated infection caused by PPNG the Centers for Disease Control now recommend treatment with cefoxitin 1 0 g or cefotaxime 0 5 g four times a day intravenously for at least seven days.20
In this study we examined the clinical efficacy of sultamicillin (a prodrug delivering sulbactam, a potent 13-lactamase inhibitor, plus ampicillin) and probenecid in the treatment of 113 cases of uncomplicated gonococcal urethritis in men. Seven of the patients were infected with PPNG strains. Of the 94 patients meeting the criteria for analysis at the first follow up examination, 91 (97%) including six with PPNG strains were cleared of infection. Two (3%) of the remaining three patients admitted to further sexual contact with untreated partners, and the evidence from contact tracing supports the view that these cases were probable reinfections. The third patient denied further sexual intercourse and was thus deemed to be a treatment failure. Clinically relevant side effects of sultamicillin were not evident and patient compliance was good.
In addition to the appearance of PPNG strains there has been a gradual increase in penicillin resistance during the 1970s. In 1980 Shtibel reported two strains with MICs of ampicillin >1 mg/1.2' In our study five strains had MICs of ampicillin of 0 8 mg/l and two MICs of ampicillin of 1 6 mg/l; all seven were non-PPNG strains. Six of the patients infected with these strains were cured at the first follow up examination and the seventh, with an MIC of ampicillin of 1 6 mg/l, was the only clear failure in the trial.
On the basis of this evidence it would seem that sultamicillin is a welcome and novel innovation in the oral. treatment of non-PPNG strains with high and low MICs of ampicillin and also of PPNG strains. 
